Table 3 Distribution of chronic comorbidities in chronic patients > 65 years of age during the year of study, overall and by sex and age groups

Anaemia

268 (8.1)

87 (7.7)

181 (8.4)

0.5

60 (4.3)

112 (9.0)

96 (14.9)

< 0.01

Human immunodeficiency virus (HIV)

4 (0.1)

4 (0.4)

0 (0.0)

< 0.01

4 (0.3)

0 (0.0)

0 (0.0)

0.07

Cirrhosis

210 (6.4)

73 (6.5)

137 (6.3)

0.8

111 (7.9)

72 (5.8)

27 (4.2)

< 0.01

Gastrointestinal ulcer

90 (2.7)

46 (4.1)

44 (2)

< 0.01

33 (2.3)

44 (3.6)

13 (2)

0.08

Inflammatory bowel disease

25 (7.6)

12 (1.1)

13 (0.3)

0.1

14 (1.0)

8 (0.6)

3 (0.5)

0.4

Aortic aneurysm

39 (1.2)

33 (2.9)

6 (0.3)

< 0.01

6 (0.4)

23 (1.9)

10 (1.6)

< 0.01

Ischaemic heart disease

285 (8.7)

171 (15.2)

114 (5.3)

< 0.01

83 (5.9)

126 (10.2)

76 (11.8)

< 0.01

Dysrhythmias

512 (15.6)

204 (18.1)

308 (14.2)

< 0.01

108 (7.7)

233 (18.8)

171 (26.6)

< 0.01

Hypertension

2224 (67.6)

789 (70.1)

1435 (66.2)

0.02

801 (56.8)

910 (73.4)

513 (79.7)

< 0.01

Stroke

204 (6.2)

88 (7.8)

116 (5.4)

< 0.01

44 (3.1)

95 (7.7)

65 (10.1)

< 0.01

Heart chronic failure

217 (6.6)

73 (6.5)

144 (6.6)

0.9

34 (2.4)

87 (7.0)

96 (14.9)

< 0.01

Valvular heart disease

144 (4.4)

52 (4.6)

92 (4.2)

0.6

47 (3.3)

52 (4.2)

45 (7.0)

< 0.01

Obstructive chronic pulmonary disease

268 (8.1)

148 (13.2)

120 (5.5)

< 0.01

95 (6.7)

119 (9.6)

54 (8.4)

0.03

Asthma

172 (5.2)

30 (2.7)

142 (6.6)

< 0.01

78 (5.5)

68 (5.5)

26 (4)

0.3

Arthritis

96 (2.8)

24 (2.1)

72 (3.3)

0.05

38 (2.7)

37 (3.0)

21 (3.3)

0.8

Osteoarthritis

707 (21.5)

157 (14.0)

550 (25.4)

< 0.01

284 (20.2)

294 (23.7)

129 (20.0)

0.05

Osteoporosis

806 (24.5)

28 (2.5)

778 (35.9)

< 0.01

361 (25.6)

308 (24.9)

137 (21.3)

0.1

Dementia

203 (6.2)

45 (4.0)

158 (7.3)

< 0.01

14 (1.0)

78 (6.3)

111 (17.2)

< 0.01

Epilepsy

57 (1.7)

18 (1.6)

39 (1.8)

0.7

15 (1.1)

28 (2.3)

14 (2.2)

0.04

Parkinson

75 (2.3)

34 (3.0)

41 (1.9)

0.04

21 (1.5)

38 (3.1)

16 (2.5)

0.02

Alcohol abuse

106 (3.2)

77 (6.8)

29 (1.3)

< 0.01

57 (4.0)

33 (2.7)

16 (2.5)

0.07

Substance abuse

5 (0.1)

2 (0.2)

3 (0.1)

0.8

2 (0.1)

3 (0.2)

0 (0.0)

0.4

Anxiety

607 (18.4)

128 (11.4)

479 (22.1)

< 0.01

296 (21.0)

217 (17.5)

94 (14.6)

< 0.01

Depression

525 (15.9)

104 (9.2)

421 (19.4)

< 0.01

206 (14.6)

201 (16.2)

118 (18.3)

0.1

Diabetes Mellitus

708 (21.5)

322 (28.6)

386 (17.8)

< 0.01

280 (19.9)

293 (23.6)

135 (21.0)

0.06

Dyslipidaemia

1937 (58.8)

652 (58.0)

1285 (59.3)

< 0.01

822 (58.3)

788 (63.6)

327 (50.8)

< 0.01

Obesity

683 (20.7)

224 (19.9)

459 (21.2)

0.4

294 (20.9)

287 (23.2)

102 (15.8)

< 0.01

Thyroid disorder

659 (20.0)

109 (9.7)

550 (25.4)

< 0.01

298 (21.1)

251 (20.3)

110 (17.1)

0.1

Renal chronic failure

128 (3.9)

60 (5.3)

68 (3.1)

< 0.01

15 (1.1)

62 (5.0)

51 (7.9)

< 0.01

Glaucoma

285 (8.7)

86 (7.6)

199 (9.2)

0.1

93 (6.6)

116 (9.4)

76 (11.8)

< 0.01

Active neoplasia

295 (8.9)

159 (14.1)

136 (6.3)

< 0.01

102 (7.2)

132 (10.7)

61 (9.5)

< 0.01

 Breast neoplasia

37 (1.1)

1 (0.1)

36 (1.7)

< 0.01

12 (0.9)

17 (1.4)

8 (1.2)

0.4

  Prostate neoplasia

55 (1.7)

55 (4.9)

0 (0.0)

< 0.01

20 (1.4)

23 (1.9)

12 (1.9)

0.6

  Colorectal neoplasia

38 (1.2)

19 (1.7)

19 (0.9)

0.04

15 (1.1)

16 (1.3)

7 (1.1)

0.8

  Skin neoplasia

37 (1.1)

13 (1.2)

24 (1.1)

0.9

10 (0.7)

20 (1.6)

7 (1.1)

0.9

  Lung neoplasia

24 (0.7)

13 (1.2)

11 (0.5)

0.04

11 (0.8)

6 (0.5)

7 (1.1)

0.3

  Lymphoma

32 (0.9)

10 (0.9)

22 (1.0)

0.7

10 (0.7)

19 (1.5)

3 (0.5)

0.03

  Bladder neoplasia

23 (0.7)

21 (1.9)

2 (0.1)

< 0.01

9 (0.6)

8 (0.6)

6 (0.9)

0.7

  Leukaemia

19 (0.5)

11 (1.0)

8 (0.4)

0.03

5 (0.4)

10 (0.8)

4 (0.6)

0.3